<code id='13888BE0FD'></code><style id='13888BE0FD'></style>
    • <acronym id='13888BE0FD'></acronym>
      <center id='13888BE0FD'><center id='13888BE0FD'><tfoot id='13888BE0FD'></tfoot></center><abbr id='13888BE0FD'><dir id='13888BE0FD'><tfoot id='13888BE0FD'></tfoot><noframes id='13888BE0FD'>

    • <optgroup id='13888BE0FD'><strike id='13888BE0FD'><sup id='13888BE0FD'></sup></strike><code id='13888BE0FD'></code></optgroup>
        1. <b id='13888BE0FD'><label id='13888BE0FD'><select id='13888BE0FD'><dt id='13888BE0FD'><span id='13888BE0FD'></span></dt></select></label></b><u id='13888BE0FD'></u>
          <i id='13888BE0FD'><strike id='13888BE0FD'><tt id='13888BE0FD'><pre id='13888BE0FD'></pre></tt></strike></i>

          fashion

          fashion

          author:focus    Page View:46316
          Sen. Bob Menendez (D-N.J.) Michael M. Santiago/Getty Images

          WASHINGTON — With mounting calls for embattled Sen. Bob Menendez to resign, the pharmaceutical industry could see one of its historical, and increasingly rare, Democratic allies ousted from Congress.

          The New Jersey senator is embroiled in another financial scandal after last week’s indictment over hundreds of thousands of dollars he and his wife allegedly accepted to influence military aid. The charges — which Menendez insists he will beat — come roughly seven years after he was accused of pressuring Medicare officials to resolve a dispute in favor of a lavish political donor. That case ended in a hung jury.

          advertisement

          But this time around, Capitol lawmakers and New Jersey Democrats including Sen. Cory Booker, a longtime legislation partner, are calling on Menendez to resign. The mounting pressure and looming court battle spell out a hazy future for one of the pharmaceutical industry’s biggest allies in the Democratic Party.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          What does generative AI mean for health care? We asked experts
          What does generative AI mean for health care? We asked experts

          MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

          read more
          Top private equity targets in 2023: cardiology, clinical trials, lasers
          Top private equity targets in 2023: cardiology, clinical trials, lasers

          AdobeBysomemeasures,privateequityinvestmentlaggedin2023,ayearmarkedbygrowingdistressandhigh-profiled

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          Genentech weighs delaying cancer therapy after drug pricing law

          GenentechCEOAlexanderHardyGenentechWASHINGTON—PlentyofpharmaceuticalexecutiveshavedecriedDemocrats’n